Skip to main content

European Medical Solutions (0RGO.L)

London Stock Exchange Healthcare BiotechnologyView data quality →
54.7Fair

ValueMarkers Composite Index

Top 51%#21,707 of 44,722

DCF data not available

Piotroski
8/9
Strong
Beneish
-2.63
Low Risk
Altman
1.37
Distress
DCF Value
-
N/A
ROIC
4.8%
Low
P/E
0.1
Value
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

European Medical Solutions (0RGO.L) — VMCI valuation read

European Medical Solutions (0RGO.L) carries a VMCI composite of 55/100, 5 points above the Healthcare sector median of 50. Among mid-cap names, that gap places 0RGO.L in the top third on the five-pillar weighting (Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%).

The 0RGO.L insider tape has been silent for the past 30 days on Form 4. Where executives neither buy nor sell, the bull and bear cases lean harder on filings cadence and the next earnings line.

**Investor frame.** Value reads 0RGO.L trades at 22.0x earnings, 22% above the Healthcare median of 18.0x, which compresses or extends through the 11.0x EV/EBITDA versus a Healthcare 12.0x. Quality: ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%). Risk: net debt to EBITDA of -1.2x leaves covenant headroom, the line to track on European Medical Solutions's next 10-Q.

0RGO.L rose 2.3% over the trailing 7 days, with a -8.2% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.